Edwards Lifesciences Corp - Common Stock (EW)

Historical Holders from Q1 2014 to Q3 2025

Symbol
EW on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
590M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
491M
Holdings value
$38.1B
% of all portfolios
0.024%
Grand Portfolio weight change
-0.001%
Number of holders
1233
Number of buys
532
Number of sells
-545
Average Value change %
-0.01%
Average buys %
+0.003%
Average sells %
-0.017%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edwards Lifesciences Corp - Common Stock (EW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.72% $5.27B 69.1M The Vanguard Group 31 Dec 2024
BlackRock, Inc. 7.5% $3.44B 44.3M BlackRock, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 3.4% $1.55B 19.8M Wellington Management Group LLP 30 Jun 2025

Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 491M $38.1B -$832M $77.77 1,233
2025 Q2 502M $39.2B +$342M $78.21 1,244
2025 Q1 499M $36.1B -$465M $72.48 1,190
2024 Q4 502M $37.2B +$1.43B $74.03 1,216
2024 Q3 476M $31.4B -$1.42B $65.99 1,173
2024 Q2 491M $45.3B +$714M $92.37 1,277
2024 Q1 485M $46.3B +$852M $95.56 1,262
2023 Q4 478M $36.4B -$1.18B $76.25 1,238
2023 Q3 493M $34.2B -$197M $69.28 1,208
2023 Q2 494M $46.5B -$182M $94.33 1,271
2023 Q1 496M $41B -$929M $82.73 1,232
2022 Q4 506M $37.8B -$184M $74.61 1,211
2022 Q3 509M $42.1B -$190M $82.63 1,228
2022 Q2 509M $48.4B +$313M $95.09 1,254
2022 Q1 508M $59.7B -$873M $117.72 1,299
2021 Q4 515M $66.6B -$187M $129.55 1,305
2021 Q3 513M $58.1B +$238M $113.21 1,216
2021 Q2 511M $53B +$538M $103.57 1,177
2021 Q1 508M $42.5B -$423M $83.64 1,126
2020 Q4 514M $46.9B +$9.98M $91.23 1,145
2020 Q3 514M $41B +$889M $79.82 1,071
2020 Q2 503M $34.8B +$22.9B $69.11 1,026
2020 Q1 169M $31.8B -$671M $188.62 994
2019 Q4 172M $40B +$49.6M $233.29 1,076
2019 Q3 172M $37.7B -$179M $219.91 952
2019 Q2 173M $31.9B +$290M $184.74 907
2019 Q1 175M $33.5B -$303M $191.33 915
2018 Q4 177M $27.1B +$78.8M $153.17 866
2018 Q3 175M $30.5B +$111M $174.10 846
2018 Q2 175M $25.5B +$115M $145.57 831
2018 Q1 174M $24.3B +$51.6M $139.52 806
2017 Q4 174M $19.6B -$380M $112.71 770
2017 Q3 177M $19.3B +$152M $109.31 738
2017 Q2 176M $20.8B +$123M $118.24 715
2017 Q1 177M $16.6B +$771M $94.07 681
2016 Q4 180M $16.9B -$154M $93.70 672
2016 Q3 180M $21.7B +$145M $120.56 689
2016 Q2 179M $17.9B -$88.1M $99.73 684
2016 Q1 180M $15.9B -$228M $88.21 640
2015 Q4 183M $14.4B +$7.5B $78.98 594
2015 Q3 87.9M $12.5B +$395M $142.17 560
2015 Q2 85.1M $12.1B -$825M $142.43 573
2015 Q1 90.9M $12.9B -$25.2M $142.46 567
2014 Q4 91.8M $11.7B -$61.7M $127.38 551
2014 Q3 92.1M $9.41B -$119M $102.15 484
2014 Q2 93.3M $8.01B -$353M $85.84 421
2014 Q1 97.6M $7.24B -$68.6M $74.17 402